NCT07576049

Brief Summary

colorectal cancer: single center experience

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
37

participants targeted

Target at P25-P50 for all trials

Timeline
8mo left

Started Jan 2026

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress35%
Jan 2026Dec 2026

Study Start

First participant enrolled

January 1, 2026

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

May 3, 2026

Completed
5 days until next milestone

First Posted

Study publicly available on registry

May 8, 2026

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2026

Last Updated

May 8, 2026

Status Verified

January 1, 2026

Enrollment Period

12 months

First QC Date

May 3, 2026

Last Update Submit

May 3, 2026

Conditions

Colorectal Cancer (Diagnosis)

Outcome Measures

Primary Outcomes (2)

  • survival

    survival

    from enrolment to end of treatment at 5 years

  • colorectal cancer survival

    survival

    From enrolment to the end of treatment at 5 years follow-up

Study Arms (1)

colorectal cancer patients

colorectal cancer diagnosis

Eligibility Criteria

Sexall(Gender-based eligibility)
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients operated to Policlinico Umberto I Hospital

You may qualify if:

  • colorectal cancer

You may not qualify if:

  • emergency setting

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Paolo Sapienza

Roma, Italy

Location

MeSH Terms

Conditions

Colorectal NeoplasmsDisease

Condition Hierarchy (Ancestors)

Intestinal NeoplasmsGastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesGastrointestinal DiseasesColonic DiseasesIntestinal DiseasesRectal DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
5 Years
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

May 3, 2026

First Posted

May 8, 2026

Study Start

January 1, 2026

Primary Completion (Estimated)

December 31, 2026

Study Completion (Estimated)

December 31, 2026

Last Updated

May 8, 2026

Record last verified: 2026-01

Locations

IT(1)